Navigating the rules of leadership, workforce and workplaces: Experts decode 2026 trends

After a year many leaders describe as ‘relentless’, the pharma, medtech, and diagnostics industry is entering 2026 with the rules of leadership, work, and value creation being rewritten in real time.

For people and culture experts Maree Paras, Associate Director of Paras and Partners, and Vanessa Meikle, CEO of Hunton Executive, 2025 did not register as merely another challenging year. It marked a structural departure from the past.

“2025 was a year of constriction and constraint,” Meikle told Health Industry Hub. “There was deep uncertainty about what would happen next, both geopolitically and domestically. Many people compared it to the Global Financial Crisis, but it wasn’t the same. It was less predictable and far less cyclical. We had not experienced anything quite like it before.”

Paras echoed the sentiment. “If there’s one word that consistently comes up when healthcare leaders talk about 2025, it’s ‘relentless,’” she said, describing a year shaped not by one crisis, but “by the accumulation of pressures.”

How Will 2026 Be Different?

Both leaders caution against expecting a dramatic easing of pressure. But they do see a shift in how organisations are responding.

“There is a noticeable shift in mindset among boards and executives – from caution to readiness,” said Meikle.

“2026 doesn’t necessarily bring less pressure, but it does bring greater realism,” Paras told Health Industry Hub. “Organisations are clearer about what’s achievable, what’s not, and where they genuinely need to focus. People and culture strategies are no longer sitting on the sidelines. They’re becoming central to how organisations plan for stability and growth.

Cost Pressures Force Difficult Trade-Offs

Across the industry, leaders are being forced to balance growth and financial pressures. Compounding the local regulatory demands and the fatigue of navigating relentless government bureaucracy, Australia’s position in the global healthcare market has also shifted. In many cases, it is no longer being treated as strategically central. The consequences are rippling through launch decisions, budgets, resourcing models, and performance targets.

“At its core, the reality for all businesses comes down to revenue and profit,” said Meikle. “Over the past year, margins, revenue, and profitability have been impacted – there is no question about that.”

The structural consequences of this pressure?

“As healthcare leaders balance long-term growth ambitions with short-term financial constraints, every role is under greater scrutiny,” explained Paras. “Leaders are being asked not just who they need, but why they need them.”

“One clear pattern we are seeing is the ‘de-ranking’ of roles, with VP roles replaced by Executive Directors and Senior Directors by Directors,” highlighted Meikle.

AI Moves from Concept to Operating System

Artificial intelligence (AI) is no longer a side conversation. It is now embedded in strategic planning, organisational design, and performance models.

“The reality is that AI represents a new industrial revolution. It is no longer theoretical, it is here,” explained Meikle. “AI plays a critical role at every stage of this journey. It elevates data from being informative to being truly strategic.”

But the risks are neither abstract nor distant.

“At the same time, the threats are real. AI will replace certain roles where work can be automated. There are also legitimate concerns around data leakage, privacy, and intellectual property,” she added.

Yet Paras warned that the experience of AI is not uniform across the organisation.

“From an employee perspective, the experience can feel very different,” she emphasised, citing concerns about job security, skills obsolescence, and the pace of change. “The real risk isn’t AI itself; it’s how organisations introduce it. Where AI is positioned as a cost-cutting tool without context, trust erodes.”

Restructuring as an Operating Condition

Workforce changes and restructuring of roles are no longer episodic. There is a high degree of uncertainty, and for the first time in many years, there is no clear or predictable cycle.

“For many employees, restructuring no longer feels like an event, it feels like a constant,” reflected Paras. She warned that while these changes may drive efficiency, they also carry risk.

“Loss of institutional knowledge, reduced engagement, and leadership burnout are becoming more common,” she added.

Meikle noted little evidence that this cycle is slowing down. “Will there be more restructures? Most likely, yes,” she said, pointing to AI-enabled role replacement, cost pressures, and shifting priorities.

The Flexibility Fault Line

One of the most contentious shifts emerging in 2026 is the move back toward office-based work.

“My sense is that we will see a move to four to five days per week on-site,” Meikle said, noting that many organisations are now prioritising execution, alignment, and pace.

Yet, Paras warned that the shift is landing uneasily with much of the workforce.

“For many employees, that move hasn’t been well received,” she emphasised. “Flexibility isn’t viewed as a perk anymore, it’s an expectation. Removing it without clear rationale can damage trust, engagement and retention.”

Leadership, Rewritten

Both people and culture experts agree that leadership capability will be the defining factor of success in 2026.

“Healthcare leaders are being asked to lead through more ambiguity, communicate clearly in uncertain environments, and balance empathy with accountability,” said Paras. “People are no longer looking for perfection. They’re looking for honesty, consistency and direction.”

For Meikle, the unfolding of the new year represents something different: not relief, but readiness.

“Organisations have spent time reacting, stabilising, and taking action during the constriction. There is renewed energy to pivot, focus on the future, and ‘get on with it’ so businesses are positioned to return to growth in 2027,” she concluded.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.